"It ain't over 'til it's over"a-The search for treatments and cures for Alzheimer's disease

ACS Medicinal Chemistry Letters

Volumn 3, Issue 11, 2012, Pages 862-866

  Hargreaves, Richard J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; AVAGECESTAT; BAPINEUZUMAB; BIOLOGICAL MARKER; CHOLINESTERASE INHIBITOR; CRENEUZEMAB; DONEPEZIL; GAMMA SECRETASE; GAMMA SECRETASE INHIBITOR; GANTENERUMAB; MEMANTINE; MONOCLONAL ANTIBODY; PLACEBO; PRESENILIN 1; PRESENILIN 2; SOLENUZEMAB; TAU PROTEIN; UNCLASSIFIED DRUG; XANOMELINE;

ALZHEIMER DISEASE; AMYLOID PLAQUE; BRAIN EDEMA; COGNITIVE DEFECT; DISEASE COURSE; DRUG APPROVAL; DRUG EFFICACY; DRUG MEGADOSE; DRUG SCREENING; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; GENETIC PREDISPOSITION; HEALTH CARE COST; HUMAN; LONGEVITY; MICROGLIA; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPROTECTION; PALLIATIVE THERAPY; PATENT; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW;

EID: 84868705553     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml300359g     Document Type: Review

References (10)

1. Selkoe, D. J. Preventing Alzheimer's Disease Science 2012, 337, 1488-1492
2. Jack, C. R.; Knopman, D. S.; Jagust, W. J.; Shaw, L. M.; Aisen, P. S.; Weiner, M. W.; Petersen, R. C.; Trojanowski, J. Q. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade Lancet Neurol. 2010, 9, 119-128
3. Karran, E.; Mercken, M.; DeStrooper, B. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics Nature Rev. Drug Discovery 2011, 10, 698-712
4. Jonsson, T.; Atwar, J. K.; Steinberg, S.; Snaedal, J.; Jonsson, P. V.; Bjornsson, S.; Stefansson, H.; Sulem, P.; Gudbjartsson, D.; Maloney, J.; Hoyte, K.; Gustafson, A.; Liu, Y.; Lu, Y.; Bhangale, T.; Graham, R. R.; Huttenlocher, J.; Bjornsdottir, G.; Andreassen, O. A.; Jonsson, E. G.; Palotie, A.; Behrens, T. W.; Magnusson, O. T.; Kong, A.; Thorsteinsdottir, U.; Watts, R. J.; Stefansson, K. A mutation in APP protects against Alzheimer's disease and age-related cognitive decline Nature 2012, 488, 96-99
5. Kung, H. F. The β-Amyloid Hypothesis in Alzheimer's Disease: Seeing Is Believing ACS Med. Chem. Lett. 2012, 3, 265-267
6. Weiner, M. W.; Veitch, D. P.; Aisen, P. S.; Beckett, L. A.; Cairns, N. J.; Green, R. C.; Harvey, D.; Jack, C. R.; Jagust, W.; Liu, E.; Morris, J. C.; Petersen, R. C.; Saykin, A. J.; Schmidt, M. E.; Shaw, L.; Siuciak, J. A.; Soares, H.; Toga, A. W.; Trojanowski, J. Q. Alzheimer's Disease Neuroimaging Initiative. The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception Alzheimer's Dementia 2012, 8, S1-S68
7. DeStrooper, B.; Vassar, R.; Golde, T. The secretases: enzymes with therapeutic potential in Alzheimer disease Nature Rev. Neurol. 2010, 6, 99-107
8. Liu, L.; Drouet, V.; Wu, J. W.; Witter, M. P.; Small, S. A.; Clelland, C.; Duff, K. Trans-Synaptic Spread of Tau Pathology In Vivo PLoS ONE 2012, 7, 1-9
9. Mandelkow, E.-M.; Mandelkow, E. Biochemistry and Cell Biology of Tau Protein in Neurofibrillary Degeneration Cold Spring Harbor Perspect. Med. 2012, 2, a006247
10. Mayeux, R. Early Alzheimer's Disease N. Engl. J. Med. 2012, 362 (23) 2194-2201